Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension.
about
The effects of short-term alpha-ketoisocaproic acid supplementation on exercise performance: a randomized controlled trialL-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infantsRoles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in ratsPhysical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice.Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats.Pediatric Primary Pulmonary Hypertension.New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy.Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2001.New treatments for pulmonary arterial hypertension.A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.Amino acid supplementation and impact on immune function in the context of exercise.Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.The ergogenic potential of arginine.Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertensionMedical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine.Advances in the medical treatment of pulmonary hypertension.Hypoxic pulmonary hypertension (HPH) and iptakalim, a novel ATP-sensitive potassium channel opener targeting smaller arteries in hypertension.International Society of Sports Nutrition position stand: energy drinksChronic hypoxia decreases arterial and venous compliance in isolated perfused rat lungs: an effect that is reversed by exogenous L-arginine.Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy.Emerging therapies for pulmonary arterial hypertension.Current and future therapy for pulmonary hypertension in patients with right and left heart failure.Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.Novel investigational therapies for treating pulmonary arterial hypertension.Application of nitric oxide measurements in clinical conditions beyond asthma.Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.Treatment of pulmonary hypertension.The effects of 4 weeks of an arginine-based supplement on the gas exchange threshold and peak oxygen uptake.The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction.L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog.[Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications].Scientific Opinion on the substantiation of health claims related to L arginine and “immune system functions” (ID 455, 1713), growth or maintenance of muscle mass (ID 456, 1712, 4681), normal red blood cell formation (ID 456, 664, 1443, 1712), mai...
P2860
Q21245428-2C8F348C-F69C-4CFB-91BB-6EC5F507A1B6Q26829856-698A8C0A-A640-45E8-A9F4-8946B0EE6431Q28578942-61A3C197-D5B4-4DC3-860B-02FC067D0F66Q31046745-D68DF961-4996-462C-8CCB-8FF04424B1EFQ33269510-A43944C2-85B3-47EF-BDCC-5195E66E3D61Q34349810-8DE81A2C-5930-4AA4-9244-96CA02E1E5EEQ34484036-8695F1FF-5A93-4AE8-A20D-62D3CB80C982Q34550155-651F7D7F-1853-4016-B462-616DA5111F60Q34625826-935ADD8C-F0F5-43D9-8AF6-30E3C9B26C2BQ34689447-EA7C1256-6647-4241-9FD4-06C5C4340212Q34746445-229E31D7-0F69-41C5-A033-BB3CAD6F0263Q34778575-B92B65DE-0A5A-4881-8A5A-90BC8AB779B2Q34781531-E1702558-8549-4994-B910-EB7AABFBEFF4Q35380577-BDB28254-FC77-4B15-9395-63F4879ABD68Q36107232-1FF8432D-95FF-4453-9EF9-58527FF24892Q36420236-4DCDFDC6-DC2F-4158-A55E-922F45367F8EQ36449206-C13B0EF1-073C-43F8-B279-99297B55A8B9Q36513263-B2F9B247-CC67-4F6D-88FC-D0D1F996E600Q36528050-4918D64E-5D3B-434A-B66A-A294698BE3DDQ36810804-70DDAEBB-C754-40B1-95E8-E8AEE8AC22C4Q36821361-4FCE682D-E24A-4E59-898C-53E5C1DCDE11Q37688167-80405D8C-C417-48C2-BC0C-569A3DEB9F42Q37823027-28D42867-EC45-4757-A066-87011C7D7312Q37867664-3A189856-2F69-4E0C-9A0C-500628022B31Q37879213-F51384A9-6B0C-4E69-A291-8A2436B95BDBQ38119018-B6E12FEB-AE9D-42C9-89F6-CBED8BA50E33Q38612061-41DA3F96-7765-4660-8D37-C3269F3E05B8Q38670757-4FAC06D3-80A5-4AE1-B512-B6A6F37C7702Q39226887-4100A1AA-EB69-4CE0-9C17-827C4D737D09Q39317865-530808E1-3397-42E0-9AE6-7DE072E3EF4DQ42782703-3EEEF86B-589E-4C10-B364-94FEA790BFFFQ43016341-186F7F73-11CA-4A5A-8D46-396603A57037Q43101543-FE69D25C-B99E-4E24-833C-0789108DEC5EQ43136761-D7CD0119-F484-47F7-AA47-368C2EB7B964Q44355177-74D53D78-FA5C-426A-B3B6-3E5772E61931Q44907812-1D51E2E9-09C3-4179-B965-079D51A2FB07Q46061181-ABBFA50B-D211-42BA-8609-60294D83D703Q46475512-A01A1D88-373A-4F71-ADB4-7A238309006EQ46486715-AD1D46B4-DFF1-4B3F-AB2E-B06B9A3A6CEDQ47149677-FBA406DC-0F16-454B-BA6E-E8CFF7AD4233
P2860
Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Short-term oral administration ...... illary pulmonary hypertension.
@en
Short-term oral administration ...... illary pulmonary hypertension.
@nl
type
label
Short-term oral administration ...... illary pulmonary hypertension.
@en
Short-term oral administration ...... illary pulmonary hypertension.
@nl
prefLabel
Short-term oral administration ...... illary pulmonary hypertension.
@en
Short-term oral administration ...... illary pulmonary hypertension.
@nl
P2093
P2860
P1476
Short-term oral administration ...... illary pulmonary hypertension.
@en
P2093
Miyatake K
Nakanishi N
Sakamaki F
Yamagishi M
P2860
P304
P356
10.1164/AJRCCM.163.4.2007116
P407
P577
2001-03-01T00:00:00Z